NLB 2014: Case Studies| Int’l Myeloma Fndn

What Is Multiple Myeloma?

Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows.

Case Studies #4 and #5: Relapsed Myeloma

Sandra Kurtin, RN, MS, AOCN®, ANP-C
Beth Faiman, PhDc , MSN, APRN-BC, AOCN®

Case Studies in Multiple Myeloma Treatment Best Practices for Nurses presented at:

ONS 2014
NLB Satellite Symposium
May 1, 2014, Anaheim, CA

NLB 2014: Case Studies: Newly Diagnosed Multiple Myeloma, Therapies, Residual Disease

IMWG 2014: Imaging

What Is Multiple Myeloma?

Are You Newly Diagnosed?

Support Groups

Daratumumab in combination with carfilzomib and dexamethasone in lenalidomide-refractory patients with relapsed multiple myeloma

How many times can a myeloma patient undergo an autologous stem cell transplant?

Give Where Most Needed

Share On

What Is Multiple Myeloma?

Are You Newly Diagnosed?

Support Groups

NLB 2014: Case Studies: Relapsed Refractory Myeloma, Adherence, Clonal Evolution, Emerging Therapies

Daratumumab in combination with carfilzomib and dexamethasone in lenalidomide-refractory patients with relapsed multiple myeloma

How many times can a myeloma patient undergo an autologous stem cell transplant?

Give Where Most Needed